Literature DB >> 16046170

Visceral leishmaniasis in organ transplant recipients: 11 new cases and a review of the literature.

Didier Basset1, Françoise Faraut, Pierre Marty, Jacques Dereure, Eric Rosenthal, Charles Mary, Francine Pratlong, Laurence Lachaud, Patrick Bastien, Jean-Pierre Dedet.   

Abstract

Eleven new cases of visceral leishmaniasis (VL) are reported in organ transplant patients in France. The epidemiological, clinical, biological, diagnostic and therapeutic features are reviewed, based on these cases and 46 cases reported in the literature. VL was most commonly associated with renal transplantation (77% of the cases). Most patients were from Southern European countries. The main clinical symptom was fever. Leucopoenia and anaemia were the most frequent haematological disorders. Diagnosis was by direct finding of the parasite in smears of bone marrow (85.2%) or, by positive serology (90.9%). Without antileishmanial treatment, VL in transplant recipients was fatal. Treatment using either antimonials or amphotericine B gave similar cure rates of around 80% of the cases. But toxicity was higher for antimonials. Relapses occurred in 14.3%.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16046170     DOI: 10.1016/j.micinf.2005.06.002

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  18 in total

Review 1.  Diagnosis of visceral leishmaniasis: developments over the last decade.

Authors:  Gurumurthy Srividya; Arpita Kulshrestha; Ruchi Singh; Poonam Salotra
Journal:  Parasitol Res       Date:  2011-11-09       Impact factor: 2.289

Review 2.  Transmission of tropical and geographically restricted infections during solid-organ transplantation.

Authors:  P Martín-Dávila; J Fortún; R López-Vélez; F Norman; M Montes de Oca; P Zamarrón; M I González; A Moreno; T Pumarola; G Garrido; A Candela; S Moreno
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

Review 3.  Prevalence, severity, and pathogeneses of anemia in visceral leishmaniasis.

Authors:  Yasuyuki Goto; Jingjie Cheng; Satoko Omachi; Ayako Morimoto
Journal:  Parasitol Res       Date:  2016-11-07       Impact factor: 2.289

4.  Seronegative visceral leishmaniasis with relapsing and fatal course following rituximab treatment.

Authors:  A Casabianca; M Marchetti; F Zallio; E Feyles; E Concialdi; E Ferroglio; A Biglino
Journal:  Infection       Date:  2011-05-03       Impact factor: 3.553

5.  Asymptomatic Leishmania infantum infection in an area of northwestern Italy (Piedmont region) where such infections are traditionally nonendemic.

Authors:  Alberto Biglino; Cesare Bolla; Erika Concialdi; Anna Trisciuoglio; Angelo Romano; Ezio Ferroglio
Journal:  J Clin Microbiol       Date:  2009-11-18       Impact factor: 5.948

6.  Leishmania major infection in a patient with visceral leishmaniasis: treatment with Amphotericin B.

Authors:  Mehdi Karamian; Mohammad Hossein Motazedian; Davood Mehrabani; Khodakaram Gholami
Journal:  Parasitol Res       Date:  2007-07-22       Impact factor: 2.289

7.  [Sepsis-like disease in an immunocompromised patient with a travel history to Mallorca].

Authors:  G C Hagenah; T Wündisch; E Eckstein; S Zimmermann; F Holst; W Grimm; A Neubauer; M Lohoff
Journal:  Internist (Berl)       Date:  2007-07       Impact factor: 0.743

Review 8.  A critical review of the applicability of serological screening for Leishmaniasis in blood banks in Brazil.

Authors:  Wellington Francisco Rodrigues; Niege Silva Mendes; Patrícia de Carvalho Ribeiro; Daniel Mendes Filho; Ricardo Cambraia Parreira; Karen Cristina Barbosa Chaves; Melissa Carvalho Martins de Abreu; Camila Botelho Miguel
Journal:  J Parasit Dis       Date:  2020-10-08

9.  Pediatric visceral leishmaniasis in Albania: a retrospective analysis of 1,210 consecutive hospitalized patients (1995-2009).

Authors:  Raida Petrela; Loreta Kuneshka; Eli Foto; Ferit Zavalani; Luigi Gradoni
Journal:  PLoS Negl Trop Dis       Date:  2010-09-07

Review 10.  One Health: the global challenge of epidemic and endemic leishmaniasis.

Authors:  Clarisa B Palatnik-de-Sousa; Michael J Day
Journal:  Parasit Vectors       Date:  2011-10-10       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.